Max Bricchi

Direttore/Membro del Consiglio presso Bial Pharma UK Ltd.

51 anni

Consumer Services

Health Technology

Profilo

Max Bricchi is currently the Director at Bial Pharma UK Ltd.
and the Chief Commercial Officer at BIAL-Portela & Cia SA. He has an undergraduate degree from Universidad de Buenos Aires, an MBA from International Institute for Management Development, and a graduate degree from Instituto Tecnológico de Buenos Aires.

Posizioni attive di Max Bricchi

Società	Posizione	Inizio
BIAL-Portela & Cia SA BIAL-Portela & Cia SA Pharmaceuticals: MajorHealth Technology BIAL-Portela & Cia SA manufactures pharmaceutical products. It develops drugs in therapeutic areas such as antibiotics, anti-inflammatory, anti-ulcer, anti-depressants, anti-asthmatic, and analgesics. The firm also offers anti-allergic vaccines and the means of diagnosing allergies. It has two production plants and two R&D centers in the Porto area and in Bilbao, Spain. The company was founded by António Portela in 1924 and is headquartered in Coronado, Portugal.	Corporate Officer/Principal	21/04/2023
Bial Pharma UK Ltd.	Direttore/Membro del Consiglio	01/03/2023

Tutte le posizioni attive di Max Bricchi

Formazione di Max Bricchi

Universidad de Buenos Aires	Undergraduate Degree
International Institute for Management Development	Masters Business Admin
Instituto Tecnológico de Buenos Aires	Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Max Bricchi

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
BIAL-Portela & Cia SA BIAL-Portela & Cia SA Pharmaceuticals: MajorHealth Technology BIAL-Portela & Cia SA manufactures pharmaceutical products. It develops drugs in therapeutic areas such as antibiotics, anti-inflammatory, anti-ulcer, anti-depressants, anti-asthmatic, and analgesics. The firm also offers anti-allergic vaccines and the means of diagnosing allergies. It has two production plants and two R&D centers in the Porto area and in Bilbao, Spain. The company was founded by António Portela in 1924 and is headquartered in Coronado, Portugal.	Health Technology
Bial Pharma UK Ltd.